Tokyo, Oct. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061134) titled 'The effects of maca intake on skin and physical and mental health in healthy adults' on Oct. 13.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - User Life Science Co., Ltd.

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To examine the effects of maca on the physical and mental health and skin of healthy adults Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Take 400mg of maca for 4 weeks (28 days) Interventions/Control_2 - Placebo intake for 4weeks (28 days)

Eligibility: Age-lower limit - 30 years-old = Gender - Female Key inclusion criteria - (1) persons who is generally judged as healthy (2) Persons who can give voluntary written consent to participate in the present trial (3) Persons who are aware of their physical and mental fatigue and stress Key exclusion criteria - (1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study (2) persons who have changed their habitats to take supplements within past 4 weeks. (3) Persons who work in night shift or in day and night shift (4) persons who have been treated their illness or prevention in a clinic at their informed consent (5) persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6) persons with the medical histories of alcoholism or drug dependence (7) persons who might be developed allergic reaction to foods (8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period (9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10) persons who will not be judged suitable to the participants by the investigator Target Size - 30

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2026 Year 03 Month 30 Day Date of IRB - 2026 Year 03 Month 08 Day Anticipated trial start date - 2026 Year 03 Month 31 Day Last follow-up date - 2026 Year 05 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069647

Disclaimer: Curated by HT Syndication.